Momenta Pharmaceuticals, Inc. (MNTA)

[tinkershaw]

Did we listen to the same conference call? I keep hearing this refrain that there is "new found optimism" in M118. What I heard was no partner has yet been found, the environment for finding a partner for M118 has been difficult, that maybe things will be loosening up in that market, we have no specific leads but we are still out there talking about it, and in the end the drug has been sitting for so long that any interest in it cannot be real strong.

Well, my reading of it. I'm not ruling something out, but come one, a drug just cannot sit this long without interest. If someone does offer to partner, don't expect much upfront, and don't expect a rapid push through clinical trials. There obviously is not much enthusiasm for M118.

Does not mean that something might not come along, but that is my reading of the issue. It was not quite as bad as Teva's "internal" discussion on low volume copaxone (code for the drug is dead) but it was approaching it, without quite pulling the plug quite yet, as there is always hope, but not looking real good.

Tinker